Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 24 min ago
PreprintCC BY-NDbioRxiv

Reducing Neutrophil Sialic Acid Residues Alleviates Cerebral Hypoperfusion in Alzheimer's Models

  1. 1University of Southern California

Abstract

Objective: Dysregulation of the immune system is increasingly recognized as a contributor to Alzheimer's disease (AD) progression, partly through neutrophil adhesion to the cerebral vasculature, which promotes hypoperfusion in AD. Because sialic acid (SA) residues on membrane glycoproteins regulate neutrophil-endothelial interactions, we investigated whether neutrophil sialylation is altered in AD and whether reducing it improves cerebral vascular function. Approach and Results: Lectin blots of isolated neutrophils showed increased SA levels in two AD mouse models, 5xFAD and APP-SAA. We identified 2,3 sialyltransferase-IN-1 as a small-molecule inhibitor that reduces sialylation in vivo. Treating 5xFAD mice with this inhibitor decreased SA on neutrophil membranes, increased cerebral blood flow, and reduced capillary stalling. Leukocytes from patients with preclinical AD and mild cognitive impairment also had higher SA levels than those from age-matched healthy controls. Conclusions: Elevated terminal sialylation of neutrophil glycoproteins contributes to capillary stalling and cerebral hypoperfusion in AD. Neutrophil sialylation may serve as both a biomarker and a therapeutic target for improving cerebral blood flow and slowing disease progression.

Related

  1. Single residues within the YTHDF intrinsically disordered region control m6A-dependent mRNA decay
    B. Ricci, D. Sommer, D. A. Narvaez +3
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
  2. Prediction of pH-sensing histidine residues in human cells
    S. Sallah, J. Warwicker
    bioRxivPreprintCC BY-NCFull textBioinformatics & computational biologybioRxiv
  3. On-farm wastewater treatment for irrigation using biochar from local agro-residues in Obuasi, Ghana
    Lydia Otoo Amponsah, David Nartey Obemah, Belinda Lee Quayson +3
    PLOS WaterPeer-reviewedCC BY 4.0Full textMicrobiologyEnvironmental science & pollutionPLOS
  4. A Potentiometric Sensor Based on a Molecularly Imprinted Polymer Modified with Multi-Walled Carbon Nanotubes for the Selective Determination of Thiabendazole Residues in Fruit Peels.
    Mirela Samardžić, Andrea Dandić, Izabella Doris Panić +1
    Sensors (Basel, Switzerland)Peer-reviewedCC BYFull textSystems & synthetic biologyEurope PMC
  5. Structural and biochemical analysis of the IBV nsp15 endoribonuclease reveals the necessity of peripheral site residues for activity
    E. S. Tully, R. N. Kirchdoerfer
    bioRxivPreprintCC BYFull textZoology & animal behaviourbioRxiv
BibTeX
@misc{bhatt2026reducing,
  title = {{Reducing Neutrophil Sialic Acid Residues Alleviates Cerebral Hypoperfusion in Alzheimer's Models}},
  author = {N. N. Bhatt and Z. Tabrizi and J. Janulis and S. Chakraborty and M. Weick and S. A. Franciosa and G. Rodriguez Moore and C. Agatemor and J. E. Galvin and O. Bracko},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.23.753660},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.23.753660v1},
  note = {CC BY-ND},
}
RIS
TY  - UNPB
TI  - Reducing Neutrophil Sialic Acid Residues Alleviates Cerebral Hypoperfusion in Alzheimer's Models
AU  - N. N. Bhatt
AU  - Z. Tabrizi
AU  - J. Janulis
AU  - S. Chakraborty
AU  - M. Weick
AU  - S. A. Franciosa
AU  - G. Rodriguez Moore
AU  - C. Agatemor
AU  - J. E. Galvin
AU  - O. Bracko
PY  - 2026
DA  - 2026/09/23
PB  - bioRxiv
DO  - 10.64898/2026.09.23.753660
UR  - https://www.biorxiv.org/content/10.64898/2026.09.23.753660v1
AB  - Objective: Dysregulation of the immune system is increasingly recognized as a contributor to Alzheimer's disease (AD) progression, partly through neutrophil adhesion to the cerebral vasculature, which promotes hypoperfusion in AD. Because sialic acid (SA) residues on membrane glycoproteins regulate neutrophil-endothelial interactions, we investigated whether neutrophil sialylation is altered in AD and whether reducing it improves cerebral vascular function. Approach and Results: Lectin blots of isolated neutrophils showed increased SA levels in two AD mouse models, 5xFAD and APP-SAA. We identified 2,3 sialyltransferase-IN-1 as a small-molecule inhibitor that reduces sialylation in vivo. Treating 5xFAD mice with this inhibitor decreased SA on neutrophil membranes, increased cerebral blood flow, and reduced capillary stalling. Leukocytes from patients with preclinical AD and mild cognitive impairment also had higher SA levels than those from age-matched healthy controls. Conclusions: Elevated terminal sialylation of neutrophil glycoproteins contributes to capillary stalling and cerebral hypoperfusion in AD. Neutrophil sialylation may serve as both a biomarker and a therapeutic target for improving cerebral blood flow and slowing disease progression.
ER  -